Vascular-directed responses of microglia produced by methamphetamine exposure: Indirect evidence that microglia are involved in vascular repair?

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Bowyer, John F ^a   Sarkar, Sumit ^a   Tranter, Karen M ^a   Hanig, Joseph P ^b   Miller, Diane B ^c   O'Callaghan, James P ^c  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Amphetamine; Hypertension; Hyperthermia; Methamphetamine; Microglia; Neurotoxicity; Vascular damage

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CD11B ANTIGEN; CELL ANTIGEN; METHAMPHETAMINE; RAT ENDOTHELIAL CELL ANTIGEN 1; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; AIF1 PROTEIN, RAT; CALCIUM BINDING PROTEIN; CENTRAL STIMULANT AGENT; ENDOTHELIAL CELL-MONOCYTE ANTIGENS; MEMBRANE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; BRAIN BLOOD VESSEL; CELL ACTIVATION; CELL LABELING; CONTROLLED STUDY; DENDRITE; DORSAL HIPPOCAMPUS; HYPERTENSION; HYPERTHERMIA; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NERVE DEGENERATION; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PARIETAL CORTEX; PERICYTE; PERIKARYON; PYRIFORM CORTEX; RAT; SEPTUM PELLUCIDUM; THALAMUS; ANIMAL; BLOOD VESSEL; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXICITY AND INTOXICATION;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, SURFACE; BLOOD VESSELS; CALCIUM-BINDING PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; MEMBRANE GLYCOPROTEINS; METHAMPHETAMINE; MICROFILAMENT PROTEINS; MICROGLIA; NERVE DEGENERATION; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84960360121     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-016-0526-6     Document Type: Article

References (54)

1. Streit WJ. The role of microglia in brain injury. Neurotoxicology. 1996;17:671-8.
2. Streit WJ. Microglia and the response to brain injury. Ernst Schering Res Found Workshop. 2002;39:11-24.
3. Streit WJ. Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci. 2006;29:506-10.
4. Nadler JV, Perry BW, Gentry C, Cotman CW. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid. J Comp Neurol. 1980;192:333-59.
5. Lipton SA. HIV-related neurotoxicity. Brain Pathol. 1991;1:193-9.
6. Appel NM, Rapoport SI, O'Callaghan JP. Sequelae of parenteral domoic acid administration in rats: comparison of effects on different anatomical markers in brain. Synapse. 1997;25:350-8.
7. Beadell NC, Thompson EM, Delashaw JB, Cetas JS. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2012;117:781-6.
8. Ransohoff RM, Schafer D, Vincent A, Blachere NE, Bar-Or A. Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics. 2015;12:896-909.
9. Hess A, Desiderio C, McAuliffe WG. Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies. J Neurocytol. 1990;19:338-42.
10. LaVoie MJ, Card JP, Hastings TG. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol. 2004;187:47-57.
11. Bowyer JF, Peterson SL, Rountree RL, Tor-Agbidye J, Wang GJ. Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res. 1998;809:77-90.
12. Eisch AJ, Schmued LC, Marshall JF. Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse. 1998;30:329-33.
13. Schmued LC, Bowyer JF. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 1997;759:135-40.
14. O'Callaghan JP, Kelly KA, VanGilder RL, Sofroniew MV, Miller DB. Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity. PLoS One. 2014;9:e102003.
15. O'Callaghan JP, Sriram K, Miller DB. Defining "neuroinflammation". Ann N Y Acad Sci. 2008;1139:318-30.
16. Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem. 2006;96:706-18.
17. Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else? Science. 2013;339:156-61.
18. Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature. 2010;468:253-62.
19. Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci. 2014;15:300-12.
20. Prinz M, Tay TL, Wolf Y, Jung S. Microglia: unique and common features with other tissue macrophages. Acta Neuropathol. 2014;128:319-31.
21. Corps KN, Roth TL, McGavern DB. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015;72:355-62.
22. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380-97.
23. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387-94.
24. Buttini M, Limonta S, Boddeke HW. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain. Neurochem Int. 1996;29:25-35.
25. Bowyer JF, Ali S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse. 2006;60:521-32.
26. Bowyer JF, Thomas MT, Schmued LC, Ali SF. Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures and the blood-brain barrier. Ann NY Acad Sci. 2008;1139:127-39.
27. Bowyer JF, Tranter KM, Sarkar S, Raymick J, Hanig JP, Schmued LC. Systemic administration of fluoro-gold for the histological assessment of vascular structure, integrity and damage. Curr Neurovasc Res. 2014;11:31-47.
28. Kiyatkin EA, Brown PL, Sharma HS. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci. 2007;26:1242-53.
29. Sonsalla PK, Nicklas WJ, Heikkila RE. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science. 1989;243:398-400.
30. Paxinos, G. and Watson, C. The rat brain in stereotaxix coordinates. Volume 2, Academic Press, San Diego, CA.
31. Schmued LC, Stowers CC, Scallet AC, Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 2005;1035:24-31.
32. Bowyer JF, Schmued LC. Fluoro-Ruby labeling prior to an amphetamine neurotoxic insult shows a definitive massive loss of dopaminergic terminals and axons in the caudate-putamen. Brain Res. 2006;1075:236-9.
33. Cass WA, Manning MW, Dugan MT. Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats. Neurosci Lett. 1998;248:175-8.
34. Ricaurte GA, McCann UD. Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann N Y Acad Sci. 1992;648:371-82.
35. Ricaurte GA, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 1980;193:153-63.
36. Ahmed Z, Shaw G, Sharma VP, Yang C, McGowan E, Dickson DW. Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. J Histochem Cytochem. 2007;55:687-700.
37. McCann MJ, O'Callaghan JP, Martin PM, Bertram T, Streit WJ. Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegeneration. Neuroscience. 1996;72:273-81.
38. Brock TO, O'Callaghan JP. Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system. J Neurosci. 1987;7:931-42.
39. Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther. 2004;311:1-7.
40. Katsumoto A, Lu H, Miranda AS, Ransohoff RM. Ontogeny and functions of central nervous system macrophages. J Immunol. 2014;193:2615-21.
41. Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16:358-72.
42. Rice RA, Spangenberg EE, Yamate-Morgan H, Lee RJ, Arora RP, Hernandez MX, et al. Elimination of microglia improves functional outcomes following extensive neuronal loss in the hippocampus. J Neurosci. 2015;35:9977-89.
43. Kelly KA, Miller DB, Bowyer JF, O'Callaghan JP. Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine. J Neurochem. 2012;122:995-1009.
44. O'Callaghan JP, Kelly KA, Locker AR, Miller DB, Lasley SM. Corticosterone primes the neuroinflammatory response to DFP in mice: potential animal model of Gulf War Illness. J Neurochem. 2015;133:708-21.
45. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19:312-8.
46. Thomas DM, Kuhn DM. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res. 2005;1050:190-8.
47. Kiyatkin EA. Brain hyperthermia during physiological and pathological conditions: causes, mechanisms, and functional implications. Curr Neurovasc Res. 2004;1:77-90.
48. Polesskaya O, Silva J, Sanfilippo C, Desrosiers T, Sun A, Shen J, et al. Methamphetamine causes sustained depression in cerebral blood flow. Brain Res. 2011;1373:91-100.
49. Bowyer JF, Patterson TA, Saini UT, Hanig JP, Thomas M, Camacho L, et al. Comparison of the global gene expression of choroid plexus and meninges and associated vasculature under control conditions and after pronounced hyperthermia or amphetamine toxicity. BMC Genomics. 2013;14:147.
50. Thomas M, George NI, Patterson TA, Bowyer JF. Amphetamine and environmentally induced hyperthermia differentially alter the expression of genes regulating vascular tone and angiogenesis in the meninges and associated vasculature. Synapse. 2009;63:881-94.
51. Kamouchi M, Ago T, Kitazono T. Brain pericytes: emerging concepts and functional roles in brain homeostasis. Cell Mol Neurobiol. 2011;31:175-93.
52. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010;68:409-27.
53. Sarkar S, Schmued L. In vivo administration of fluorescent dextrans for the specific and sensitive localization of brain vascular pericytes and their characterization in normal and neurotoxin exposed brains. Neurotoxicology. 2012;33:436-43.
54. Levi MS, Patton RE, Hanig JP, Tranter KM, George NI, James LP, et al. Serum myoglobin, but not lipopolysaccharides, is predictive of AMPH-induced striatal neurotoxicity. Neurotoxicology. 2013;37C:40-50.